18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms

Clinical trial NCT03121599 · TERMINATED

Trial details

NCT number: NCT03121599
Sponsor: Hamad Medical Corporation
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Essential Thrombocythemia Primary Myelofibrosis, Fibrotic Stage Primary Myelofibrosis, Prefibrotic Stage Polycythemia Vera

Start date: 2017-06-11
Primary completion: 2018-10-15
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.